Galaxy Medicare's IPO Set to Strengthen Manufacturing Capabilities

Galaxy Medicare Limited is launching its IPO to raise ₹ 22.31 Crores, with proceeds focused on enhancing manufacturing capabilities and meeting growing market demands. The IPO, open from September 10-12, 2025, aims to expand their Bhubaneswar facility and fund working capital. Galaxy serves global markets with its diversified medical products.

On September 9, 2025, Galaxy Medicare Limited announced the opening of its Initial Public Offering (IPO) to raise ₹ 22.31 Crores. The offering, scheduled from September 10 to 12, targets expanding the company's manufacturing capabilities by purchasing advanced machinery for the Bhubaneswar facility.

Galaxy Medicare, a prominent player in the medical devices and healthcare industry, aims to attract institutional, non-institutional, and individual investors. The IPO consists of 41,32,000 equity shares at a price band of ₹ 51 - ₹ 54 per share, listed on the NSE Emerge platform.

The funds will be strategically utilized to boost production efficiency, support working capital, and expand the company's market footprint, both domestically and internationally. With over 27 registered trademarks, Galaxy Medicare continues to supply essential medical products globally, leveraging its strong brand portfolio.